News und Analysen
Here's Why Immunomedics Rose as Much as 14.2% Today
Shares of preclinical biopharma Immunomedics (NASDAQ: IMMU) gained over 14% today without any company-specific news. However, earlier in the day, the nearly $12 billion buyout of Kite Pharma by....
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
bluebird bio (NASDAQ: BLUE) is up 9.5% and Juno Therapeutics (NASDAQ: JUNO) is up 17% at 12:40 p.m. EDT Monday. Both appear to be riding the coattails of fellow immuno-oncology drug developer Kite....
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
bluebird bio (NASDAQ: BLUE) is up 9.5% and Juno Therapeutics (NASDAQ: JUNO) is up 17% at 12:40 p.m. EDT Monday. Both appear to be riding the coattails of fellow immuno-oncology drug developer Kite....
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
bluebird bio (NASDAQ: BLUE) is up 9.5% and Juno Therapeutics (NASDAQ: JUNO) is up 17% at 12:40 p.m. EDT Monday. Both appear to be riding the coattails of fellow immuno-oncology drug developer Kite....
Gilead's Plan? Cash In on CAR-T
Investors eagerly awaiting news of how Gilead Sciences' (NASDAQ: GILD) plans to spend its growing mountain of cash found out on Monday that the company's plans to become a leader in cancer....
Gilead's Plan? Cash In on CAR-T
Investors eagerly awaiting news of how Gilead Sciences' (NASDAQ: GILD) plans to spend its growing mountain of cash found out on Monday that the company's plans to become a leader in cancer....
Gilead's Plan? Cash In on CAR-T
Investors eagerly awaiting news of how Gilead Sciences' (NASDAQ: GILD) plans to spend its growing mountain of cash found out on Monday that the company's plans to become a leader in cancer....
Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?
Gilead Sciences (NASDAQ: GILD), prompted by its falling sales of its hepatitis C drugs over the past year, has finally pulled the trigger on a much-anticipated buyout: On Monday, it offered to....
Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?
Gilead Sciences (NASDAQ: GILD), prompted by its falling sales of its hepatitis C drugs over the past year, has finally pulled the trigger on a much-anticipated buyout: On Monday, it offered to....
Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?
Gilead Sciences (NASDAQ: GILD), prompted by its falling sales of its hepatitis C drugs over the past year, has finally pulled the trigger on a much-anticipated buyout: On Monday, it offered to....
If You Love Intuitive Surgical, You Should Check Out This Small-Cap Growth Stock
Few companies have done more to change healthcare over the past 20 years than Intuitive Surgical (NASDAQ: ISRG). The company singlehandily brought robotic surgery to the masses and in the process....
If You Love Intuitive Surgical, You Should Check Out This Small-Cap Growth Stock
Few companies have done more to change healthcare over the past 20 years than Intuitive Surgical (NASDAQ: ISRG). The company singlehandily brought robotic surgery to the masses and in the process....
If You Love Intuitive Surgical, You Should Check Out This Small-Cap Growth Stock
Few companies have done more to change healthcare over the past 20 years than Intuitive Surgical (NASDAQ: ISRG). The company singlehandily brought robotic surgery to the masses and in the process....
In Your 60s? 3 Stocks You Might Want to Buy
For many Americans, reaching their 60s is often the point where they transition out of the labor force and into retirement. It means putting that alarm clock to bed for good and putting your feet....
In Your 60s? 3 Stocks You Might Want to Buy
For many Americans, reaching their 60s is often the point where they transition out of the labor force and into retirement. It means putting that alarm clock to bed for good and putting your feet....
Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.But there were some investors who did something on that date who probably recall it with a smile.....
Can Buying Exelixis Stock Still Make You Rich?
What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.But there were some investors who did something on that date who probably recall it with a smile.....
Why I Love AbbVie Inc.
"Where your treasure is, there will your heart be also."Those profound words were spoken nearly 2,000 years ago. They were true then, and they're still true today. But even when your treasure is....
Why I Love AbbVie Inc.
"Where your treasure is, there will your heart be also."Those profound words were spoken nearly 2,000 years ago. They were true then, and they're still true today. But even when your treasure is....
Why I Love AbbVie Inc.
"Where your treasure is, there will your heart be also."Those profound words were spoken nearly 2,000 years ago. They were true then, and they're still true today. But even when your treasure is....
Why You Can Back Up the Truck and Load Up on This Biotech Stock
Mae West once said, "Too much of a good thing can be wonderful." The late actress wasn't referring to investing, but her sentiment is still applicable. It makes sense to buy more shares of stocks....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
Even great companies can turn into poor investments if you buy them at the wrong time. That's why it is important to take a hard look at a company's valuation before pulling the trigger.Shares of....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
Even great companies can turn into poor investments if you buy them at the wrong time. That's why it is important to take a hard look at a company's valuation before pulling the trigger.Shares of....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
Even great companies can turn into poor investments if you buy them at the wrong time. That's why it is important to take a hard look at a company's valuation before pulling the trigger.Shares of....
Here Are the Big Pharma Stocks to Own Based on R&D Spending
Just because a big pharma company is successful today doesn't mean it will be successful in a few years. Even the biggest blockbuster drugs eventually lose patent exclusivity or face new and....